We are live on ! Find out more
BCM

Bourgeon Capital Management Portfolio holdings

AUM $679M
1-Year Est. Return 50.89%
This Fund
S&P 500
This Quarter Est. Return
+7.82%
1 Year Est. Return
+50.89%
3 Year Est. Return
+117.43%
5 Year Est. Return
+128.86%
10 Year Est. Return
+783.94%
AUM
$330M
AUM Growth
+$48.9M
Cap. Flow
+$31.4M
Cap. Flow %
9.51%
Top 10 Hldgs %
32.98%
Holding
327
New
68
Increased
65
Reduced
43
Closed
21

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$7.96M
2
FSLR icon
First Solar
FSLR
+$6.74M
3
PSX icon
Phillips 66
PSX
+$6.3M
4
GTLS
Chart Industries
GTLS
+$4.56M
5
GILD icon
Gilead Sciences
GILD
+$4.18M

Top Sells

Rank Stock Value
1
WY icon
Weyerhaeuser
WY
+$7.17M
2
BDX icon
Becton Dickinson
BDX
+$4.98M
3
NVDA icon
NVIDIA
NVDA
+$3.9M
4
IAU icon
iShares Gold Trust
IAU
+$3.25M
5
RDS.A
Royal Dutch Shell PLC ADS Class A
RDS.A
+$940K

Sector Composition

Rank Sector Weight
1 Technology 18.08%
2 Healthcare 17.45%
3 Industrials 15.82%
4 Financials 11.35%
5 Energy 7.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ZTS icon
226
Zoetis
ZTS
$30.5B
$8K ﹤0.01%
47
– –
FATE icon
227
Fate Therapeutics
FATE
$326M
$7K ﹤0.01%
175
– –
NTNX icon
228
Nutanix
NTNX
$16.9B
$7K ﹤0.01%
300
– –
XLB icon
229
State Street Materials Select Sector SPDR ETF
XLB
$8.66B
$7K ﹤0.01%
222
– –
RDS.B
230
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$7K ﹤0.01%
269
– –
BIDU icon
231
Baidu
BIDU
$37.2B
$6K ﹤0.01%
45
– –
RF icon
232
Regions Financial
RF
$26.8B
$6K ﹤0.01%
500
– –
BN icon
233
Brookfield
BN
$108B
$5K ﹤0.01%
280
– –
CPB icon
234
Campbell Soup
CPB
$6.87B
$5K ﹤0.01%
100
– –
IDYA icon
235
IDEAYA Biosciences
IDYA
$3.56B
$5K ﹤0.01%
+400
New +$4.95K
MET icon
236
MetLife
MET
$62.1B
$5K ﹤0.01%
125
-36
-22% -$1.37K
MTD icon
237
Mettler-Toledo International
MTD
$28.6B
$5K ﹤0.01%
5
– –
WAT icon
238
Waters Corp
WAT
$39.9B
$5K ﹤0.01%
25
– –
TRQ
239
DELISTED
Turquoise Hill Resources Ltd
TRQ
$5K ﹤0.01%
600
-1,000
-63% -$8.9K
BMY icon
240
Bristol-Myers Squibb
BMY
$132B
$4K ﹤0.01%
62
– –
CLF icon
241
Cleveland-Cliffs
CLF
$6.99B
$4K ﹤0.01%
600
-600
-50% -$3.61K
NTRS icon
242
Northern Trust
NTRS
$33.9B
$4K ﹤0.01%
50
– –
PANW icon
243
Palo Alto Networks
PANW
$297B
$4K ﹤0.01%
90
– –
TSLA icon
244
Tesla
TSLA
$1.3T
$4K ﹤0.01%
+30
New +$3.54K
BABA icon
245
Alibaba
BABA
$308B
$3K ﹤0.01%
10
– –
DEO icon
246
Diageo
DEO
$53.6B
$3K ﹤0.01%
25
– –
PDSB icon
247
PDS Biotechnology
PDSB
$43.4M
$3K ﹤0.01%
+1,500
New +$4.21K
UBER icon
248
Uber
UBER
$153B
$3K ﹤0.01%
+92
New +$3.04K
UL icon
249
Unilever
UL
$136B
$3K ﹤0.01%
37
– –
ZG icon
250
Zillow
ZG
$7.63B
$3K ﹤0.01%
30
– –
8 9
10
11 12

Similar funds

AP
Advisors Preferred Rockville, Maryland $679M AUM 22.19% 1-Year Est. Return
MCO
MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return
REAM
Ripple Effect Asset Management New York $679M AUM 81.6% 1-Year Est. Return
CCG
Clearlake Capital Group Santa Monica, California $680M AUM 30.34% 1-Year Est. Return
TWM
Topsail Wealth Management Charlotte, North Carolina $678M AUM 13.87% 1-Year Est. Return
CIA
Covington Investment Advisors Ligonier, Pennsylvania $680M AUM 28.91% 1-Year Est. Return
NS
Night Squared New York $681M AUM 50% 1-Year Est. Return
MMPW
Mitchell McLeod Pugh & Williams Mobile, Alabama $678M AUM 23.02% 1-Year Est. Return

Bourgeon Capital Management's Q3 2020 Portfolio in Review

As of Q3 2020, Bourgeon Capital Management held 327 positions worth $330M, up 17% from $281M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Bourgeon Capital Management deployed $31.4M of net new capital in Q3 2020, opening 68 new positions and adding to 65 existing holdings. Its largest new stake was Medtronic: 79,295 shares worth $8.24M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Weyerhaeuser, an estimated $7.17M trimmed.

  • Bourgeon Capital Management's largest Q3 2020 buy was Medtronic: 79,295 shares worth $8.24M.
  • Bourgeon Capital Management added most to First Solar in Q3 2020, an estimated $6.74M increase.
  • Bourgeon Capital Management's biggest Q3 2020 reduction was Weyerhaeuser, cutting an estimated $7.17M.
  • Bourgeon Capital Management fully exited Aimmune Therapeutics in Q3 2020, selling an estimated $154K.
  • Bourgeon Capital Management's ten largest holdings make up 33% of its $330M portfolio in Q3 2020.
  • Bourgeon Capital Management opened 68 new positions and closed 21 in Q3 2020.
  • Bourgeon Capital Management's portfolio value rose 17% quarter-over-quarter to $330M.

Based on Bourgeon Capital Management's 13F filing for Q3 2020, filed 28 Oct 2020.